VANCOUVER, BC, July 07, 2026 (GLOBE NEWSWIRE) — Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) is pleased to announce the appointment of Mr. Andrew Lau, CPA, CA, as Chief Financial Officer, effective July 6, 2026. This strategic addition to the executive team follows Rocket Doctor AI’s recent US expansion, which has increased the company’s reach to more than 21 million covered people. Mr. Lau’s leadership will be instrumental in managing the financial complexities of this rapid expansion and driving the company’s expansion strategy.
Mr. Lau brings over 18 years of capital markets, corporate finance and public company experience to Rocket Doctor AI. Throughout his career, he has held executive finance leadership roles with high-growth technology and life sciences companies, where he has led corporate finance, treasury, financial reporting, corporate development and public company initiatives. Mr. Lau began his career with Deloitte LLP, where he earned the Chartered Professional Accountant designation, before joining RBC Capital Markets as an investment banker specializing in M&A and equity financing transactions. Over the course of his career, he has advised and executed over $700 million in M&A and capital markets transactions and has been instrumental in helping emerging growth companies scale, strengthen their financial operations, and access public markets.
Dr. Essam Hamza, CEO of Rocket Doctor AI, commented: “Andrew’s appointment comes at a critical juncture for our company as we accelerate our expansion into the US market. After an extensive and rigorous search, we are thrilled to have someone of his caliber join the team. His strategic financial rigor is exactly what is needed to support our expansion and ensure we take advantage of the larger opportunities ahead.”
Mr. Lau said: “I am incredibly excited to join Rocket Doctor AI at this important moment in the company’s trajectory. The ability to combine advanced AI with scalable healthcare solutions is unmatched. Having followed the company’s expansion over the past six months, I am impressed by the announced significant US footprint and its growing patient numbers. I look forward to applying my experience to drive operational excellence and create lasting value for our shareholders and patients.”
Mr Lau replaces Mr Chris Cherry, who is stepping down as interim CFO to return to his role as Chairman of the Audit Committee while continuing to serve as a Director. Management and the Board are extremely grateful to Mr. Cherry for stepping up to provide critical financial leadership and stable guidance during this seamless transition.
The Company has granted a total of 263,250 stock options, exercisable at $0.70 per share, and 319,830 restricted share units to Mr. Lau, supporting advisors and employees. Stock options and restricted share units are valid for a period between three to five years and are subject to vesting provisions. Stock options and restricted share units are subject to the terms of the Company’s equity compensation plans and applicable securities law hold periods.
About Rocket Doctor AI Inc.
Rocket Doctor AI Inc. provides physician-built, AI-powered solutions designed to make high-quality health care accessible throughout the patient journey. The cornerstone of the company’s proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians around the world.
Along with GLM is Rocket Doctor Inc. and its AI-powered digital health platform and marketplace. Having helped empower more than 750,000 MDs to care for more than 350,000 patients, our proprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices – improving efficiency, restoring autonomy to MDs and expanding patient access to care.
By reducing administrative burden and ensuring greater consistency in care, our technology creates more time for meaningful physician-patient interactions. We are committed to reaching underserved, rural and remote communities in Canada who often lack access to family doctors and supporting patients on Medicaid and Medicare in the United States. With advanced AI, large language models and connected medical devices, Rocket Doctor AI is redefining modern healthcare – making it more scalable, equitable and patient-centric.
To learn more about Rocket Doctor AI Inc.’s products and services, contact:
www.rocketdoctor.ai or email: (email protected)
For additional information contact:
Dr. Essam Hamza, CEO, Rocket Doctor AI
For media inquiries contact: (email protected)
Call: +1 (778) 819 8321
Cautionary Statements
This news release contains forward-looking statements and other statements relating to the future operations of Rocket Doctor AI Inc. that are not historical facts. Forward-looking statements are often identified by words such as “will,” “may,” “should,” “anticipate,” “expect,” and similar expressions. All statements other than statements of historical fact included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events may differ materially from those anticipated in such statements. Such forward-looking statements include, without limitation, statements regarding the anticipated benefits of Mr. Lau’s appointment as Chief Financial Officer, the Company’s ability to execute on its U.S. expansion strategy, its ability to capitalize on its expanded reach of covered life, and its expectation of continued growth and shareholder value creation. Important factors that could cause actual results to differ materially from Rocket Doctor AI Inc.’s expectations include the failure to retain key management personnel or realize the anticipated benefits of Mr. Lau’s appointment, the Company’s ability to successfully execute its U.S. market expansion strategy, changes in regulatory requirements applicable to virtual healthcare services in Canada or the United States, changes in the competitive landscape for digital healthcare services, risks associated with operating in a highly regulated healthcare environment and others detailed in filings made by Rocket Doctor AI Inc. from time to time. There are risks involved. Securities regulator.
The reader is cautioned that the assumptions used in preparing any forward-looking information may prove to be incorrect. Actual results may differ from anticipated results due to events or circumstances resulting from numerous known and unknown risks, uncertainties and other factors, many of which are beyond the control of Rocket Doctor AI Inc. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ from those anticipated. The forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements included in this news release are made as of the date of this news release and Rocket Doctor AI Inc. will publicly update or revise the included forward-looking statements only as expressly required by Canadian securities law.